首页 | 本学科首页   官方微博 | 高级检索  
检索        

p53通路微小RNA在卵巢癌细胞和浆液性卵巢癌组织中的表达及意义
作者姓名:Zhang Q  He XJ  Ma LP  Li N  Yang J  Cheng YX  Cui H
作者单位:1. 100044,北京大学人民医院临床分子生物学研究所
2. 100044,北京大学人民医院妇科肿瘤中心
摘    要:目的 探讨微小RNA (miRNA) miR-449a、miR-449b和miR-192家族是否与miR-34家族一样可作为p53通路成员,在卵巢癌中发挥作用.方法 以DNA损伤药物阿霉素处理p53野生型卵巢癌A2780细胞,采用Western blot法检测A2780细胞中p53蛋白的表达改变,采用实时定量PCR法检测激活p53后miR-449a/b、miR-34a、miR-34b、miR-34c、miR-192和miR-194的表达.在P53突变型卵巢癌SKOV3.ipl细胞中过表达miRNA,检测SKOV3.ipl细胞的细胞周期改变.采用实时定量PCR法检测miR-449a/b、miR-34a、miR-34b、miR-34c、miR-192和miR-194在正常输卵管以及不同分级分期的浆液性卵巢癌组织中的表达.结果 在阿霉素处理后24h,卵巢癌A2780细胞中p53蛋白的表达明显升高,miR-34b、miR-34c、miR-449a/b的表达约升高19 ~ 21倍,但miR-192和miR-194的表达未见明显变化.转染miR-449b和miR-34c后,SKOV3.ipl细胞出现G1期阻滞.miR-449a/b在浆液性卵巢癌组织中的表达改变与miR-34b和miR-34c基本平行,它们在高级别和晚期浆液性卵巢癌组织中的表达水平,显著低于正常输卵管组织以及低级别和早期浆液性卵巢癌组织;miR-192、miR-194和miR-34a在卵巢癌组织中的表达未发现明显的特征,在正常输卵管组织中的表达也明显低于miR-449a/b、miR-34b和miR-34c.结论 miR-449a/b与miR-34b、miR-34c作为抑癌基因,在p53通路中发挥协同作用,它们的功能缺失与浆液性卵巢癌的发生、发展密切相关.

关 键 词:微小RNA  p53通路  卵巢肿瘤

Expression and significance of microRNAs in the p53 pathway in ovarian cancer cells and serous ovarian cancer tissues
Zhang Q,He XJ,Ma LP,Li N,Yang J,Cheng YX,Cui H.Expression and significance of microRNAs in the p53 pathway in ovarian cancer cells and serous ovarian cancer tissues[J].Chinese Journal of Oncology,2011,33(12):885-890.
Authors:Zhang Qi  He Xiang-jun  Ma Li-ping  Li Na  Yang Jing  Cheng Ye-xia  Cui Heng
Institution:Institute of Clinical Molecular Biology, Peking University People's Hospital, Beijing 100044, China.
Abstract:Objective The aim of this study was to investigate whether miR-449a,miR-449b and miR-192 family microRNAs play the same roles in p53 pathway as miR-34 family in ovarian cancer.Methods Wild-type p53 ovarian carcinoma cell line A2780 cells were treated with genotoxic agent adriamycin.The reactivation of p53 was detected by Western blot.The expression of miR-449a/b,miR-34a,miR-34b,miR-34c,miR-192 and miR-194 were detected by real-time quantitative PCR.Mutant p53 ovarian cancer cell line SKOV3.ipl cells were transfected with pre-microRNAs and the cell-cycle changes were detected.The expression level of miR-449a/b,miR-34a,miR-34b,miR-34c,miR-192 and miR-194 in serous ovarian carcinomas of varying grade and stage were compared with real-time PCR.Results The expressions of miR-449a/b,miR-34b and miR-34c were 19-fold to 21-fold elevated after p53 activation by genotoxic agent. Ectopic expression of miR-449b,as well as miR-34c,resulted in cell-cycle arrest in SKOV3.ipl cells.The expression of miR-449a/b was parallel with that of miR-34b,miR-34c,and were significantly lower in late stage and high-grade serous carcinomas than in the normal fallopian tube,early stage and low-grade serous carcinomas.The expression of miR-192,miR-194 and miR-34a did not show evident features in serous ovarian carcinomas and were much lower than miR-449a/b,miR-34b and miR-34c in normal fallopian tube.Conclusions As tumor-suppressor microRNAs,miR-449a/b,miR-34b and miR-34c cooperate and play important roles in p53 pathway. Their inactivation may contribute to the carcinogenesis and progression of serous ovarian carcinomas.
Keywords:MicroRNA  P53 pathway  Ovarian neoplasms
本文献已被 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号